Item 4, purpose of the transaction:Item 4 is hereby amended and restated in its entirety to read as follows: Each of FLS IX, FLS X, FLSPF, FLS XI and FLS XII acquired the FLS IX Shares, the FLS X Shares, the FLSPF Shares, the FLS XI Shares and the FLS XII Shares, as the case may be, for investment purposes. Depending on market conditions, its continuing evaluation of the business and prospects of the Issuer and other factors, FLS IX, FLS X, FLSPF, FLS XI and FLS XII and the other Reporting Persons may dispose of or acquire additional shares of the Issuer. Except as set forth above, none of the Reporting Persons has any present plans which relate to or would result in: (a) The acquisition by any person of additional securi…Read the filing
Mirum Pharmaceuticals, Inc. MIRM
Institutional owners are on their way
13F data can be up to 45 days oldWe read every 13F filing after each quarter ends. The owners of MIRM show here after the next update.
Institutional ownership
Institutional owners
Institutional owners are on their wayWe read every 13F filing after each quarter ends. The owners of MIRM show here after the next update.
Funds that hold MIRM
Mutual funds and ETFs, each from its own latest portfolio report. Funds report on their own quarter ends.
Fund holdings are on their wayWe read the funds' N-PORT reports after each quarter. The funds that hold MIRM show here after the next update.
Superinvestors holding MIRM
The investors followed on Tickdelta, from their latest 13F.
| Investor | Quarter | Shares | Value | % of portfolio | Last quarter |
|---|---|---|---|---|---|
| Polen Capital Polen Capital Management | Jun 30, 2026 | 21K | $2.4M | 0.02% | Added +1.8% |
13D filings: owners who may push for change
Owners of more than 5%
Sources
SEC's Form 13F data sets, each quarter; Form N-PORT data sets for the funds; Schedule 13D filings.
Also
Investors: the portfolios of the superinvestors followed here. Insider trades: what the company's own people bought and sold.